Zepbound® (tirzepatide) for weight management explained: side effects, important safety warnings, how to take Zepbound, and how it works for weight loss and long-term weight management. If you've been prescribed Zepbound—or you're considering it—this video breaks down the information you’re likely looking for, clearly and without all the hype. Zepbound contains tirzepatide, a medication that acts on both GIP and GLP-1 receptors. For weight management, it is FDA-approved for long-term weight reduction and maintenance in certain adults with obesity or overweight with at least one weight-related health condition, together with a reduced-calorie diet and increased physical activity. In this Rehealthify explainer, you'll learn why Zepbound may be prescribed, the common side effects and important safety risks, how the once-weekly subcutaneous treatment is taken, and what tirzepatide is actually doing inside the body. We also explain how Zepbound affects appetite, fullness, food intake, and stomach emptying, why treatment typically involves gradual dose increases, and why ongoing communication with your healthcare team matters. Zepbound is also FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity, but this video focuses primarily on its use for weight management. CHAPTERS 00:00 Introduction 00:13 Why It's Prescribed 00:33 Side Effects & Safety 01:39 How to Take It 02:12 How It Works 02:40 Treatment Support 03:22 The Big Picture COMMON SIDE EFFECTS & SAFETY Common side effects discussed in the video include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection-site reactions, fatigue, hypersensitivity or allergic reactions, burping, hair loss, and acid reflux. The video also covers important safety information, including serious gastrointestinal reactions, dehydration-related kidney injury, gallbladder problems, pancreatitis, serious allergic reactions, and Zepbound's boxed warning concerning thyroid C-cell tumors observed in animal studies. It is not known whether Zepbound causes these tumors in humans. Zepbound should not be used in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Because tirzepatide delays stomach emptying, it may affect the absorption of some oral medications. Patients should also tell their healthcare team they are taking Zepbound before surgery or procedures involving anesthesia or deep sedation. If pregnancy is recognized, Zepbound should be discontinued. Talk with a qualified healthcare professional about pregnancy, medications, side effects, and questions specific to your treatment. For more clear, evidence-based health information without the hype, subscribe to Rehealthify. Medical Disclaimer:This content is for educational and informational purposes only and is not medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding your health, medications, and treatment decisions. Do not start, stop, change, or adjust Zepbound or any other prescription medication based solely on information in this video. Follow the treatment and dosing instructions provided by your healthcare professional and the current prescribing information for your medication. Sources & References U.S. National Library of Medicine — DailyMedZepbound® (tirzepatide) Full Prescribing Information and FDA-approved Medication Guide, revised August 2026:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b U.S. Food and Drug Administration (FDA)FDA Approves New Medication for Chronic Weight Management — Zepbound (tirzepatide):https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management U.S. Food and Drug Administration (FDA)FDA Approves Zepbound for Moderate-to-Severe Obstructive Sleep Apnea in Adults With Obesity:https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea National Library of Medicine — MedlinePlusTirzepatide Injection Drug Information:https://medlineplus.gov/druginfo/meds/a622044.html Independence Disclosure:Rehealthify is an independent health-information and education channel. This video is educational and is not an endorsement or recommendation of Zepbound or any other medication. Rehealthify is not affiliated with or sponsored by the manufacturer of Zepbound unless explicitly stated otherwise. Zepbound® is a registered trademark of its respective owner. Use of the name is for identification and educational purposes only. #zepbound #tirzepatide #weightmanagement #weightlossmedications #glp1